OKYO Pharma (OKYO) Expected to Post Quarterly Earnings on MondayMarket Beat·Aug 3 at 10:11 AMOKYO-293.00%
OKYO Pharma files Form 3 for Chief Scientific Officer Rajkumar V. PatilPUBT·Jul 29 at 03:35 PMOKYO-293.00%
OKYO Pharma (NASDAQ:OKYO) Is In A Good Position To Deliver On Growth PlansSimplywall·Jul 27 at 06:30 AMOKYO-293.00%
OKYO Pharma Director Ups Stake Ahead of Planned Phase 3 Neuropathic Corneal Pain TrialTip Ranks·Jul 23 at 11:27 AMOKYO-293.00%
OKYO Pharma Announces Purchase of Shares by Chief Executive OfficerUnusual Whales·Jul 23 at 06:02 AMOKYO-293.00%
OKYO Pharma Announces Purchase of Shares by Director | OKYO Stock NewsStockTitan·Jul 23 at 03:00 AMOKYO-293.00%
OKYO Pharma Executive Boosts Shareholding Ahead of Planned Phase 3 NCP TrialTip Ranks·Jul 22 at 09:27 AMOKYO-293.00%
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director | OKYO Stock NewsStockTitan·Jul 22 at 01:00 AMOKYO-293.00%
